NRXP
NRx Pharmaceuticals, Inc.
NASDAQ · Healthcare · Biotechnology · US
$3.45
+0.58%Leverage
- Debt / equity
- -7.33x
- Net debt / equity
- 149.65x
- Debt / assets
- 0.04x
- Debt / EBITDA
- -0.06x
- Net debt / EBITDA
- 1.16x
Liquidity & coverage
- Current ratio
- 0.86x
- Quick ratio
- 0.86x
- Cash ratio
- 0.79x
- Interest coverage
- -17.45x
- EBITDA / interest
- -19.20x
- Working capital
- -$4.7M
Cash & dividend
- FCF / debt
- -16.59x
- Cash flow / debt
- -15.87x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Jun 1, 2026